HNN3.0
Register
Register
Register

Project cooperationUpdated on 12 December 2025

Functional molecules development and synthesis

Project Manager at Sikemia

Grabels, France

About

SIKÉMIA, is a French company with Dual-Skills:

-         Strong background for the tailor-made design and scale-up of reactants, linkers, coupling agents.

-         High competence in surface functionalization to provide new properties like reactive functions, easy to clean, bio-immobilisation, filler compatibilization… to material surfaces.

You can visit our website http://www.sikemia.com

SiKEMIA can synthesize tailor made functional molecules in the Si, S, P and carbonyle chemistries. Our glasswares equipment allows us to perform syntheses from g to KG scale.

Topic

  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential

Type

  • Partner seeks Consortium/Coordinator

Organisation

Sikemia

Company (SME)

Grabels, France

Similar opportunities

  • Project cooperation

    Advanced Nanoparticle Platforms for Targeted Therapeutics and Gene Delivery

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions

    Paola Astolfi

    Associate professor at Università Politecnica delle Marche

    Ancona, Italy

  • Project cooperation

    Adenoviral vaccine platform

    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential

    Angelo Raggioli

    Head of Technology Development at ReiThera srl

    Rome, Italy

  • Project cooperation

    Protein design, modelling, optimisation

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential

    Abdullah Kahraman

    Professor of Data Science in Life Sciences at School of Life Sciences, University of Applied Sciences Northwestern Switzerland

    Muttenz, Switzerland